STOCK TITAN
  1. Home
  2. Sec-filings
  3. JAZZ
  4. [144] Jazz Pharmaceuticals plc SEC Filing

Jazz Pharma (NASDAQ: JAZZ) director plans 857,602 stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) has a notice of proposed sale filed under Rule 144 for common stock held for the account of director Patrick Kennedy. The filing lists 3,507 shares of common stock, to be sold through E*TRADE Financial Corporation on NASDAQ in connection with restricted stock vesting on August 28, 2026, categorized as compensation. The Form 144 is signed by Paz Dizon under power of attorney for Patrick Kennedy on August 31, 2026.

Positive

  • None.

Negative

  • None.
Shares of common stock 3,507 shares Amount of Jazz Pharmaceuticals plc common stock listed in the Form 144 securities information and securities to be sold sections
Aggregate value 857,602.00 Aggregate value associated with 3,507 shares of common stock in the securities information section
CUSIP-like identifier 64914577 Identifier listed in the securities information section for the common stock
Vesting date 08/28/2026 Date of restricted stock vesting for the common shares categorized as compensation
Form 144 signature date 08/31/2026 Date of signature by Paz Dizon under power of attorney for Patrick Kennedy
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
restricted stock vesting financial
"COMMON | 08/28/2026 | RESTRICTED STOCK VESTING | ISSUER"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
power of attorney regulatory
"Signature | /s/Paz Dizon by power of attorney for Patrick Kennedy"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
compensation financial
"3507 | 08/28/2026 | Compensation"
Form 144 regulatory
"144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

What does the Form 144 filing by JAZZ director Patrick Kennedy disclose?
It discloses a proposed sale under Rule 144 of 3,507 shares of Jazz Pharmaceuticals plc common stock held for Patrick Kennedy’s account, relating to restricted stock vesting on August 28, 2026, with the transaction categorized as compensation.

How many JAZZ shares are covered by this Form 144 notice?
The notice covers 3,507 shares of Jazz Pharmaceuticals plc common stock. These shares are associated with restricted stock vesting dated August 28, 2026, and are reported as securities to be sold under Rule 144.

What is the approximate aggregate value reported for the JAZZ shares in this Form 144?
The Form 144 lists an aggregate value of 857,602.00 for the 3,507 shares of Jazz Pharmaceuticals plc common stock. This figure appears in the securities information section alongside the share amount and NASDAQ listing reference.

On which market are the JAZZ shares in this Form 144 intended to be sold?
The filing indicates that the common stock of Jazz Pharmaceuticals plc referenced in the Form 144 is traded on NASDAQ, and E*TRADE Financial Corporation is listed in the securities information section as the broker.

What is the nature and date of the JAZZ securities to be sold under this Form 144?
The securities to be sold are common shares of Jazz Pharmaceuticals plc arising from restricted stock vesting on August 28, 2026. The filing categorizes the transaction type as Compensation and reports the same date for the securities to be sold.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR